These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 12771144)

  • 1. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
    Sliva D; Rizzo MT; English D
    J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
    Philip S; Kundu GC
    J Biol Chem; 2003 Apr; 278(16):14487-97. PubMed ID: 12473670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
    Mahabeleshwar GH; Das R; Kundu GC
    J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
    Bone H; Williams NA
    Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
    Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
    Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
    Sliva D; English D; Lyons D; Lloyd FP
    Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR; Beaulieu LM; Carter JC; Church FC
    Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation.
    Zheng DQ; Woodard AS; Tallini G; Languino LR
    J Biol Chem; 2000 Aug; 275(32):24565-74. PubMed ID: 10835423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
    Chung TW; Lee YC; Kim CH
    FASEB J; 2004 Jul; 18(10):1123-5. PubMed ID: 15132991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
    Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.
    Madge LA; Pober JS
    J Biol Chem; 2000 May; 275(20):15458-65. PubMed ID: 10748004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells.
    Chang MS; Lee WS; Chen BC; Sheu JR; Lin CH
    Mol Pharmacol; 2004 Sep; 66(3):561-71. PubMed ID: 15322248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.